Skip to main content

LabCorp to Validate Roche s AmpliChip, Help Evaluate Leukemia Microarray

NEW YORK, July 25 (GenomeWeb News) - Laboratory Corporation of America will start validating Roche Diagnostics' AmpliChip CYP450 and will help Roche evaluate its research leukemia microarray, which is currently in development, the company said on Friday.

 

Roche's AmpliChip CYP450, which is built around Affymetrix's DNA chips, is designed to help physicians select dosing regimens for drugs covering a broad array of conditions, including cardiac diseases, chronic pain, cancer, and common psychiatric disorders.

 

Its leukemia microarray, which also uses AmpliChip technology, is designed to identify subclasses of leukemia.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.